Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty

BACKGROUND: Tranexamic acid (TXA) is effective in reduction of hemorrhage after major surgical procedures. In total joint replacement it is commonly administered intravenously. Despite various studies regarding the safety of its antifibrinolytic effect there are contraindications for systemic use. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Tille, Eric, Mysliwietz, Jonas, Beyer, Franziska, Postler, Anne, Lützner, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661102/
https://www.ncbi.nlm.nih.gov/pubmed/31351459
http://dx.doi.org/10.1186/s12891-019-2715-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661102/
https://www.ncbi.nlm.nih.gov/pubmed/31351459
http://dx.doi.org/10.1186/s12891-019-2715-9

Ejemplares similares